Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 291-813-1 | CAS number: 90480-76-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-07-28 to 2017-09-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (adopted July 21, 1997)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-[(5-amino-4-methylpentyl)amino]-3-(2-methylphenoxy)-propan-2-ol
- Cas Number:
- 1617528-43-4
- Molecular formula:
- C16H28N2O2
- IUPAC Name:
- 1-[(5-amino-4-methylpentyl)amino]-3-(2-methylphenoxy)-propan-2-ol
- Reference substance name:
- 1,1'-[(2-Methyl-1,5-pentanediyl)diimino]bis[3-(2-methylphenoxy)-propan-2-ol]
- Cas Number:
- 1617528-45-6
- Molecular formula:
- C26H40N2O4
- IUPAC Name:
- 1,1'-[(2-Methyl-1,5-pentanediyl)diimino]bis[3-(2-methylphenoxy)-propan-2-ol]
- Reference substance name:
- Mephenesin
- EC Number:
- 200-427-4
- EC Name:
- Mephenesin
- Cas Number:
- 59-47-2
- Molecular formula:
- C10H14O3
- IUPAC Name:
- 3-(2-methylphenoxy)propane-1,2-diol
- Reference substance name:
- 1,3-bis(2-methylphenoxy)propan-2-ol
- Cas Number:
- 17181-49-6
- Molecular formula:
- C17H20O3
- IUPAC Name:
- 1,3-bis(2-methylphenoxy)propan-2-ol
- Reference substance name:
- 2-methylpentane-1,5-diamine
- EC Number:
- 239-556-6
- EC Name:
- 2-methylpentane-1,5-diamine
- Cas Number:
- 15520-10-2
- Molecular formula:
- C6H16N2
- IUPAC Name:
- 2-methylpentane-1,5-diamine
- Reference substance name:
- 3,3’-(5-(2-hydroxy-3-(o-tolyloxy)propylamino)-4-methylpentylazanediyl)bis(1-(o-tolyloxy)propan-2-ol)
- Molecular formula:
- C36H52N2O6
- IUPAC Name:
- 3,3’-(5-(2-hydroxy-3-(o-tolyloxy)propylamino)-4-methylpentylazanediyl)bis(1-(o-tolyloxy)propan-2-ol)
- Test material form:
- liquid
Constituent 1
Constituent 2
impurity 1
impurity 2
impurity 3
impurity 4
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- provided by the sponsor
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature, protected from light and under nitrogen
- Solubility of the test substance in the solvent/vehicle:
test substance formed a clear solution in ethanol at a concentration of approximately 500 mg/mL with sonication at 37.0ºC for 20 minutes
- Stability of the test substance in the solvent/vehicle:
stable in ethanol, at concentrations of 0.0314 and 59.0 mg/mL, at room temperature for at least 3.5 hours, and at a concentration of 99.1 mg/mL for at least 3.1 hours.
Method
- Target gene:
- histidine locus of several Salmonella typhimurium strains
tryptophan locus of Escherichia coli strain WP2 uvrA
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- preliminary toxicity assay: 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333, and 5000 µg per plate
initial mutagenicity assay 5.00, 15.0, 50.0, 150, 500, 1500 and 3000 µg per plate (tester strains TA98, TA1537 and WP2 uvrA in the presence and absence of S9 activation, and TA100 in the presence of S9 activation) and 1.50, 5.00, 15.0, 50.0, 150, 333 and 500 µg per plate (tester strains TA100 in the absence of S9 activation, and TA1535 in the presence and absence of S9 activation).
retest of mutagenicity assay: 5.00, 15.0, 50.0, 150, 500, 1500, 3000, and 5000 µg per plate with tester strain TA1535 in the presence of S9 activation
protocol criteria for top dose or toxicity were met - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: solubility pretest
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: 2 aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation)
DETERMINATION OF CYTOTOXICITY
- Method: thinning of the microcolony lawn
METHOD OF APPLICATION: in agar (plate incorporation)
NUMBER OF REPLICATIONS: main test was performed in triplicates
DETERMINATION OF CYTOTOXICITY
- Method: thinning of the microcolony lawn - Rationale for test conditions:
- The study was concluded to be negative without conducting a confirmatory (independent repeat) assay because the results were clearly negative; hence, no further testing was warranted.
- Evaluation criteria:
- For each replicate plating, the mean and standard deviation of the number of revertants per plate were calculated and are reported.
For the test substance to be evaluated positive, it must cause a dose-related increase in the mean revertants per plate of at least one tester strain over a minimum of two consecutive increasing concentrations of test substance as specified below:
Data sets were judged positive if the increase in mean revertants at the peak of the dose-response was equal to or greater than 3.0-times (Strains TA1535 and TA1537) respectively equal to or greater than 2.0-times (Strains TA98, TA100 and WP2 uvrA) the mean vehicle control value and above the corresponding acceptable vehicle control range.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium, other: TA98, TA100, TA1535, TA1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation observed up to the limit dose
- Other confounding effects: no
- Sterility Results: No contaminant colonies were observed on the sterility plates for the vehicle control, the test substance dilutions or the S9 and Sham mixes.
RANGE-FINDING/SCREENING STUDIES:
A range-finding study was conducted in all tester strains. Toxicity was observed beginning at 100, 333, 667, 1000, and 3333 µg per plate with all conditions.
Main test:
Toxicity was observed beginning at 150, 333, 1500, and 3000 µg per plate with all conditions except tester strain TA1535 in the presence of S9 activation
No precipitate was observed.
TA1535:
In the retest of mutagenicity assay, the dose levels tested were 5.00, 15.0, 50.0, 150, 500, 1500, 3000, and 5000 µg per plate with tester strain TA1535 in the presence of S9 activation. No precipitate was observed. Toxicity was observed beginning at 1500 µg per plate. No positive mutagenic responses were observed for the test substance.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: given in report
- Negative (solvent/vehicle) historical control data: given in report
Any other information on results incl. tables
Preliminary Toxicity Assay
Tester Strains |
Without metabolic activation (µg per plate) |
With metabolic activation (µg per plate) |
Toxicity |
Toxicity |
|
TA98 |
≥ 1000 |
≥ 3333 |
TA100 |
≥ 333 |
≥ 1000 |
TA1535 |
≥ 100a |
≥ 667 |
TA1537 |
≥ 667 |
≥ 3333 |
WP2uvrA |
≥ 1000 |
≥ 3333 |
aToxicity was observed as a reduction in revertant counts.
Toxicity levels in main test
Tester Strains |
Without metabolic activation (µg per plate) |
With metabolic activation (µg per plate) |
Toxicity |
Toxicity |
|
TA98 |
≥ 1500 |
3000 |
TA100 |
≥ 150 |
≥ 1500 |
TA1535 |
≥ 333 |
- |
TA1537 |
≥ 1500 |
3000 |
WP2uvrA |
≥ 1500 |
3000 |
In order to achieve the protocol criteria for top dose or toxicity, the test condition TA1535 in the presence of S9 activation was repeated.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study, CGE-PMDA adduct did not cause a positive mutagenic response with any of the tester strains in either the presence or absence of Aroclor induced rat liver S9. All criteria for a valid study were met as described in the protocol.
- Executive summary:
In a reverse gene mutation assay in bacteria according to OECD guideline 471 (adopted 21 July 1997), Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and Escherichia coli strain WP2 uvrAwere exposed to CGE-PMDA adduct in ethanol in concentrations of 0 (control), 5.00, 15.0, 50.0, 150, 500, 1500 and 3000 µg per plate (tester strains TA98, TA1537 and WP2 uvrA in the presence and absence of S9 activation, and TA100 in the presence of S9 activation) and 1.50, 5.00, 15.0, 50.0, 150, 333 and 500 µg per plate (tester strains TA100 in the absence of S9 activation, and TA1535 in the presence and absence of S9 activation). In the retest of mutagenicity assay, the dose levels tested were 5.00, 15.0, 50.0, 150, 500, 1500, 3000, and 5000 µg per plate with tester strain TA1535 in the presence of S9 activation.The assay was performed using the plate incorporation method.
The test substance was tested up to cytotoxic concentrations.Toxicity was observed beginning at 150, 333, 1500 and 3000 µg per plate with all conditions except tester strain TA1535 in the presence of S9 activation. In order to achieve the protocol criteria for top dose or toxicity, the test condition TA1535 in the presence of S9 activation was repeated.Toxicity was then observed beginning at 1500 µg per plate.Precipitation was not observed. The positive controls induced the appropriate responses in the corresponding strains. The mean numbers of revertant colonies in the negative controls were within the ranges of the historical control data.
There was no evidence of an increase in the number of revertant colonies that was equal to or greater than 3.0-times the mean vehicle control value in strains TA1535 and TA 1537 or exceeded twice the background in the tester strains TA98, TA100 and WP2 uvrA examined at the peak of the dose-response. Therefore, test substance was considered to be non-genotoxic (nonmutagenic) in Salmonella tester strains TA98, TA100, TA1535, TA1537 andEscherichia coli strain WP2 uvrA under the conditions employed (plate incorporation assay).
Under the conditions of the study, the test substance was negative for mutagenic potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.